Founded with the mission to revolutionize ophthalmic care, Altris.AI offers a deep learning SaaS and mobile app designed for the automated detection and analysis of ocular diseases. The company's vision is to enhance the accuracy and efficiency of diagnosing retinal conditions through advanced AI technology. Their platform provides automatic, quantitative analysis of OCT scans, making it an invaluable tool for ophthalmologists and optometrists. Altris.AI focuses on the healthcare market, specifically targeting eye care professionals and institutions.
Notable achievements include FDA clearance, CE certification, and compliance with GDPR and HIPAA standards, underscoring their commitment to regulatory excellence. The platform is compatible with all OCT devices, broadening its accessibility and utility. Altris.AI has garnered industry recognition through various awards and positive reviews, solidifying its impact in the field of ophthalmology. The company continues to push the boundaries of medical imaging technology, improving diagnostic capabilities and patient outcomes globally.
